Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Apartment Investment and Management Company (NYSE:AIV) Trades Near 52-Week Low as Liquidation Plan Rolls On

The company has a marketCapitalizationof about USD 228.75 million at the current price. Aimco owns 95.1% of the legal interest in the commonPartnershipunits of Aimco Operating Partnership, which holds all of its assets.

Nitish Kishor | 07 November 2026

What Investors Are Watching at Aptiv PLC (NYSE:APTV) as the Stock Nears a 52-Week Low

Aptiv has a marketCapitalizationof about USD 8.13 billion at the current price and a price to earnings ratio of 38.10. It describes itself as a global industrial technology company serving automotive, commercial vehicle, aerospace and defense, telecom and datacom, and other industrial end markets.

Nitish Kishor | 07 November 2026

Why Is Ardelyx (NASDAQ:ARDX) Trading Near a 52-Week Low With Revenue Up 16%?

Ardelyx has a marketCapitalizationof about USD 737.78 million at the current price. Management said its two first in class medicines, IBSRELA and XPHOZAH, generated over USD 125 million in revenue in the quarter, up 19% from a year ago.

Nitish Kishor | 07 November 2026

Arvinas (NASDAQ:ARVN) Stock: PROTAC Update Due in Mid-2027 as Shares Near 52-Week Low

Arvinas has a marketCapitalizationof about USD 426.31 million at the current price. It is a clinical stage biotechnology company pioneering a new class of medicines through its PROTAC protein degradation platform.

Nitish Kishor | 07 November 2026

Axon Enterprise (NASDAQ:AXON) Drops 16% to a 52-Week Low Despite 28% Sales Growth

The company has a marketCapitalizationof about USD 26.04 billion at the current price. Management said the fourth quarter outlook no longer includes two large federal Dedrone deployments totaling approximately USD 100 million.

Nitish Kishor | 07 November 2026

Why Did Aytu BioPharma (NASDAQ:AYTU) Stock Land Near a 52-Week Low After Fiscal 2026 Revenue Fell 13%?

Aytu has a marketCapitalizationof about USD 20.11 million at the current price. It is a specialty pharmaceutical company that in-licenses, acquires and commercializes prescription therapeutics for central nervous system conditions, including attentionDeficithyperactivity disorder.

Nitish Kishor | 07 November 2026

What Investors Are Watching at BGSF (NYSE:BGSF) as Shares Sit Near a 52-Week Low

BGSF has a marketCapitalizationof about USD 37.17 million at the current price. It operates primarily in the United States through its Property Management segment, which can service all states and the District of Columbia.

Nitish Kishor | 07 November 2026

BioStem Technologies (NASDAQ:BSEM) Stock: Second Quarter Loss of USD 9.0 Million Puts Shares Near 52-Week Low

BioStem has a marketCapitalizationof about USD 19.79 million at the current price. It had 17,849,471 shares of common stock outstanding as of August 12, 2026.

Nitish Kishor | 07 November 2026

Array Digital Infrastructure (NYSE:AD) Hits Fresh 52-Week Low as Tower Revenue Climbs 14%

Array has a marketCapitalizationof about USD 2.64 billion at the current price. It leases tower space to tenants, holds noncontrolling interests in wireless operating companies managed by Verizon and AT&T, and holds wireless spectrum licenses. It is an 81.9% ownedSubsidiaryof Telephone and Data Systems.

Nitish Kishor | 07 November 2026

BKV Corporation (NYSE:BKV) Stock: Barnett Acquisition and Convertible Notes in Focus Near 52-Week Low

BKV has a marketCapitalizationof about USD 1.95 billion and a price toEarningsratio of 6.41. There were 107,991,704 shares of common stock outstanding as of October 30, 2026.

Nitish Kishor | 07 November 2026
Support

Hi! How can we help you today?

Loading…